Ardigen Celebrates 8 Years of Innovation in AI Drug Discovery

Topic:

This year, Ardigen is celebrating its 8th anniversary. This is an excellent opportunity to recap and present plans and aspirations for both the coming year and further into the future.

Eight years in numbers – Ardigen’s development

Since 2015, we have completed over 300 projects in collaboration with more than 60 clients from the AI-driven Drug Discovery sector. We have started as a small group of biotechnology enthusiasts. Now, however, our team has expanded to 200 professionals dedicated to developing new treatments and therapies.

To all business partners and people engaged in Ardigen’s success: thank you!

We could not do it without our team members. Your resilience and expertise have become a driving force behind each of Ardigen’s milestones. Thank you for your passion and engagement in our growth.

Looking forward, we are setting our sights on more prospects of growth and innovative solutions in AI and medicine.

Let’s raise a toast to the times ahead and get ready for more groundbreaking projects!

Ardigen's 8th brithday

You might be also interested in:

BIO Convention 2025
BIO International Convention 2025 – New Standards in Collaboration, Innovation, and the Integration of AI in Biotechnology
Biologics 2.0 – From monoclonal antibodies to multispecific therapeutics
Computer Vision Meets Life Sciences: Inside the CVPR 2025 Workshop Co-Organized by Ardigen
High-performance computing servers powering biomedical data pipelines and drug discovery.
Beyond the Petabytes: What It Really Takes to Power the Next Leap in Drug Discovery

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!